Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Plasticell, Kings College Partner on Blood Platelet Substitute     | Contract Pharma
Collaborations & Alliances

Plasticell, Kings College Partner on Blood Platelet Substitute    

Will work to progress preclinical trials of artificial blood platelet product, manufactured from pluripotent stem cells

Plasticell, a developer of cell therapies, has partnered with Kings College London to progress preclinical trials of its artificial blood platelet product, manufactured from pluripotent stem cells.
  
Plasticell has developed methods of producing functional platelets from human induced pluripotent stem cells (iPSCs) and has scaled these up to intermediate bioreactor level, allowing manufacture of product for preclinical studies. Kings College will contribute expertise and in vivo models to characterize the dynamics, lifespan, safety and efficacy of transfused platelets.
 
“In addition to providing a more stable and safe supply of ‘universal’ platelets, the use of iPS cells would allow us to create immunologically compatible ‘matched’ platelets for patients suffering from alloimmune refractoriness,” said Dr. Marina Tarunina, Principal Scientist leading the project at Plasticell.
 
The project is part of Plasticell’s hematopoietic cell therapy portfolio, which includes the expansion of umbilical cord- and bone- derived hematopoietic stem cells, and the manufacture of various blood cell types.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters